Shilpa Pharma

Specialized offerings

  • Home
  • »
  • Specialized offerings

Specialized Offerings

At Shilpa Pharma, we are committed to delivering cutting-edge solutions in HPAPI, Peptides, Payload Linkers, Specialty Polymers, and Specialty Chemicals. With our state-of-the-art facilities, highly skilled scientific teams, and strong regulatory compliance, we ensure seamless product development, and manufacturing. Our expertise in complex chemistry, advanced process development, and stringent quality control allows us to meet the evolving needs of the pharmaceutical industry.

HPAPI

Shilpa Pharma is a pioneer and the first company in India to establish a complete isolator technology, offering end-to-end solutions for the development and manufacturing of oncology and non-oncology high-potent compounds. Our high-containment infrastructure, designed to handle OEL bands 1 to 5 which allow us to accommodate different scales, from small-scale to large-scale. With nine dedicated cytotoxic manufacturing blocks with a dedicated Analytical lab, we have a proven track record in HPAPI manufacturing for global markets.

Peptides

Shilpa Pharma is at the forefront of peptide drug development, offering a one-stop integrated solution for peptide programs. Our expertise in solid-phase, liquid-phase, and hybrid synthesis allows us to develop Peptide based APIs. Shilpa has expertise in dealing with generic, oncology, non-oncology, peptidomimetics and custom peptides that include functional cosmetics, MAPs with high precision. Our capabilities include PEGylation, lipidation, biotinylation, sulfation, phosphorylation, and glycosylation to enhance stability, solubility, and efficacy. We provide nGMP and cGMP manufacturing, ensuring that our peptide products meet global regulatory standards. With state-of-the-art analytical characterization, purification, and stability studies, we ensure the highest purity and quality in every batch.

Payload Linkers (ADCs and PDCs)

At Shilpa Pharma, we specialize in the development of highly stable and efficient linkers for Antibody-Drug Conjugates and Peptide-Drug Conjugates, enabling the next generation of targeted cancer therapies. Our expertise in cleavable and non-cleavable linkers ensures precise payload release, enhancing the therapeutic index and reducing toxicity. We employ advanced biorthogonal and click chemistry techniques for efficient payload conjugation. Our GMP-compliant facilities support the scale-up and commercial manufacturing of payload-linkers, ensuring global regulatory compliance.

Specialty Polymers

Shilpa Pharma has a dedicated polymer research and technology division focused on the development and manufacturing of high-performance specialty polymers. Our capabilities include monomer synthesis, polymer modification, chemical functionalization, and process development for drug delivery systems. With expertise in ring-opening polymerization and controlled radical polymerization, we provide custom polymer solutions for pharmaceutical and industrial applications. Our state-of-the-art R&D and manufacturing facilities ensure high-quality, scalable polymer production, meeting global industry standards.

Specialty Chemicals

Shilpa Pharma offers a diverse portfolio of specialty chemicals, supporting pharmaceutical and biotechnology applications. Our expertise includes custom synthesis, process optimization, and commercial-scale manufacturing of fine chemicals, advanced intermediates, and high-value specialty compounds. We leverage advanced process technologies and stringent quality control systems to ensure that every product meets regulatory and customer specifications. Our strong commitment to innovation, compliance, and sustainability makes us a trusted partner for specialty chemical development.

Flow Chemistry

At Shilpa Pharma CDMO, we are revolutionizing pharmaceutical manufacturing with cutting-edge flow chemistry solutions. Our expertise in microfluidic reactors and customized in-house designed 3D reactors allows us to optimize complex reactions with precision and efficiency.

We have successfully scaled nitration reactions, ensuring safer operations and enhanced process control. Our advanced continuous processing techniques enable the production of APIs with improved yield, reduced waste, and greater sustainability.

With a strong commitment to innovation, we deliver cost-effective and high-quality solutions for pharmaceutical development and manufacturing. Partner with us to unlock the full potential of flow chemistry.

AI

AI-Driven Innovation at Shilpa Pharma CDMO

At Shilpa Pharma CDMO, we harness the power of Artificial Intelligence to revolutionize pharmaceutical manufacturing. Our AI-driven approach enhances the Route of Synthesis (ROS), enabling more efficient and cost-effective pathways for drug development.

Through advanced AI models, we achieve optimized yield improvement by fine-tuning reaction parameters for maximum efficiency. Our technology also helps identify stoichiometric alternatives, eco-friendly solvents, reagents, and catalysts, ensuring a safer and more sustainable process. With AI-driven process control, we deliver scalable and robust manufacturing solutions, helping our partners achieve higher efficiency, reduced waste, and superior-quality compounds.